Roche's diagnostics division saw a year-over-year sales increase of 14% in 2020 to CHF 13.79bn ($15.3bn) – largely due to demand for COVID-19 diagnostics.
Roche Takes Advantage Of COVID-19 Testing Rush
Roche’s sales in 2020 increased by 1%, at constant exchange rates, to CHF 58.3bn, led by 14% growth in its diagnostics division.
